Montoudis Alain, Seidman Ernest, Boudreau François, Beaulieu Jean-François, Menard Daniel, Elchebly Mounib, Mailhot Geneviève, Sane Alain-Theophile, Lambert Marie, Delvin Edgard, Levy Emile
Department of Nutrition, Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, Quebec, Canada.
J Lipid Res. 2008 May;49(5):961-72. doi: 10.1194/jlr.M700363-JLR200. Epub 2008 Jan 30.
The role of intestinal fatty acid binding protein (I-FABP) in lipid metabolism remains elusive. To address this issue, normal human intestinal epithelial cells (HIEC-6) were transfected with cDNA to overexpress I-FABP and compared with cells treated with empty pQCXIP vector. I-FABP overexpression stimulated mitochondrial [U-14C]oleate oxidation to CO2 and acid-soluble metabolites via mechanisms including the upregulation of protein expression and the activity of carnitine palmitoyltransferase 1, a critical enzyme controlling the entry of fatty acid (FA) into mitochondria, and increased activity of 3-hydroxyacyl-CoA dehydrogenase, a mitochondrial beta-oxidation enzyme. On the other hand, the gene and protein expression of the key enzymes FA synthase and acetyl-coenzyme A carboxylase 2 was decreased, suggesting diminished lipogenesis. Furthermore, I-FABP overexpression caused a decline in [14C]free cholesterol (CHOL) incorporation. Accordingly, a significant lessening was observed in the gene expression of Niemann Pick C1-Like 1, a mediator of CHOL uptake, along with an increase in the transcripts and protein content of ABCA1 and ABCG5/ABCG8, acting as CHOL efflux pumps. Furthermore, I-FABP overexpression resulted in increased levels of mRNA, protein mass, and activity of HMG-CoA reductase, the rate-limiting step in CHOL synthesis. Scrutiny of the nuclear receptors revealed augmented peroxisome proliferator-activated receptor alpha,gamma and reduced liver X receptor-alpha in HIEC-6 overexpressing I-FABP. Finally, I-FABP overexpression did not influence acyl-coenzyme A oxidase 1, which catalyzes the first rate-limiting step in peroxisomal FA beta-oxidation. Overall, our data suggest that I-FABP may influence mitochondrial FA oxidation and CHOL transport by regulating gene expression and interaction with nuclear receptors.
肠道脂肪酸结合蛋白(I-FABP)在脂质代谢中的作用仍不清楚。为了解决这个问题,将正常人肠道上皮细胞(HIEC-6)用cDNA转染以过表达I-FABP,并与用空pQCXIP载体处理的细胞进行比较。I-FABP的过表达通过包括上调肉碱棕榈酰转移酶1(一种控制脂肪酸(FA)进入线粒体的关键酶)的蛋白表达和活性以及增加线粒体β-氧化酶3-羟基酰基辅酶A脱氢酶的活性等机制,刺激线粒体[U-14C]油酸氧化为二氧化碳和酸溶性代谢物。另一方面,关键酶脂肪酸合酶和乙酰辅酶A羧化酶2的基因和蛋白表达降低,表明脂肪生成减少。此外,I-FABP的过表达导致[14C]游离胆固醇(CHOL)掺入量下降。因此,观察到胆固醇摄取介质尼曼-匹克C1样1的基因表达显著降低,同时作为胆固醇流出泵的ABCA1和ABCG5/ABCG8的转录本和蛋白含量增加。此外,I-FABP的过表达导致HMG-CoA还原酶(胆固醇合成中的限速步骤)的mRNA水平、蛋白量和活性增加。对核受体的研究发现,过表达I-FABP的HIEC-6中过氧化物酶体增殖物激活受体α、γ增加,而肝X受体α减少。最后,I-FABP的过表达不影响催化过氧化物酶体FAβ-氧化中第一个限速步骤的酰基辅酶A氧化酶1。总体而言,我们的数据表明,I-FABP可能通过调节基因表达以及与核受体的相互作用来影响线粒体FA氧化和CHOL转运。